 CytoDyn Inc. OTCQB:CYDY told investors it has filed a request with the US Food and Drug Administration FDA for approval of expanded access use of leronlimab for multi-drug resistance MDR HIV patients. The company said it has also previously sought FDA approval to charge for leronlimab used in this patient population and is preparing to file the last portion of the request. 